Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-30
2011-10-25
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S135000
Reexamination Certificate
active
08044068
ABSTRACT:
Disclosed is an aminopyrrolidine compound represented by the formula [I] or a pharmaceutically acceptable salt thereof. The compound or the salt is useful as a prophylactic/therapeutic agent for mode disorder such as depression, anxiety disorder, anorexia, cachexia, pain and drug dependence, whose action relies on the MC4receptor antagonistic effect.
REFERENCES:
patent: 7759336 (2010-07-01), Habashita et al.
patent: 2007/0191364 (2007-08-01), Braun et al.
patent: 2010/0261701 (2010-10-01), Kaneko et al.
patent: 2005-523237 (2005-08-01), None
patent: 03/028641 (2003-04-01), None
patent: WO2004052862 (2004-06-01), None
patent: 2005/047251 (2005-05-01), None
patent: 2006/021656 (2006-03-01), None
Caprathe et al., 2005, CAS: 142:430293.
Abe Kumi
Amada Yuri
Ishii Takaaki
Ishizaka Tomoko
Kumagai Toshihito
Nissan Chemical Industries Ltd.
Shiao Rei-tsang
Sughrue & Mion, PLLC
Taisho Pharmaceutical Co., Ltd
LandOfFree
Aminopyrrolidine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminopyrrolidine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopyrrolidine compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4293299